3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
5
Mucositis
2
Febrile Neutropenia
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Smoldering Multiple Myeloma
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Hematologic Neoplasms
1
Cytokine Release Syndrome
1
Cryopyrin-Associated Periodic Syndromes
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Fluorouracil
155
Oxaliplatin
133
Leucovorin
124
Capecitabine
90
Irinotecan
88
Radiotherapy
63
Bevacizumab
61
Cetuximab
38
Folfox protocol
25
Panitumumab
21
Neoadjuvant Therapy
21
Surgical Procedures, Operative
19
Chemotherapy, Adjuvant
15
Radiation
13
Floxuridine
13
Erlotinib Hydrochloride
13
Early Intervention, Educational
13
IFL protocol
11
Drug Therapy
11
Proctectomy
10
Magnetic Resonance Spectroscopy
10
Counseling
10
Surveys and Questionnaires
8
Sorafenib
8
Psychiatric Rehabilitation
8
Gene Expression Profiling
8
Radiotherapy, Intensity-Modulated
7
Immunohistochemistry
7
Gemcitabine
7
Celecoxib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rectal Neoplasms
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT04942626
2025-02-21
ACO/ARO/AIO-21
Goethe University
Phase 1
Completed
12 enrolled